Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-450/r/ABT-267 and ABT-333 in HCV Genotype 1b Non-cirrhotic Adults
CTR20150588Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Viekira Pak in hepatitis C virus infection, sponsored by AbbVie Inc.. Started Sep 2015; status: completed.
02
Drugs
Viekira Pak
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on CTR20150588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150588.